Lanean...
Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
Cimetidine, the first H(2) receptor antagonist in widespread clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical and clinical studies for a number of different cancer types. These data are summarised and discussed in relation to a number of distinct me...
Gorde:
| Argitaratua izan da: | Ecancermedicalscience |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Cancer Intelligence
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4268104/ https://ncbi.nlm.nih.gov/pubmed/25525463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2014.485 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|